ClinVar Miner

Submissions for variant NM_001384474.1(LOXHD1):c.977A>G (p.Asn326Ser)

gnomAD frequency: 0.00020  dbSNP: rs188528174
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000155732 SCV000205442 likely benign not specified 2016-05-21 criteria provided, single submitter clinical testing p.Asn326Ser in exon 8 of LOXHD1: This variant is not expected to have clinical s ignificance due to frequency data, conservation data, and previous reports. It has been identified in 0.9% (6/648) of East Asian chromosomes by the Exome Aggre gation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs188528174). Th e asparagine (Asn) at position 326 is not conserved in mammals or evolutionary d istant species, with two mammals (pig and armadillo) having a serine (Ser), supp orting that a change at this position may be tolerated. In addition, this varia nt has been previously reported in an individual with hearing loss by our labora tory who had an alternate explanation of the hearing loss identified. Therefor e, this data collectively suggests that the p.Asn326Ser variant is likely benign .
Labcorp Genetics (formerly Invitae), Labcorp RCV000901310 SCV001045675 likely benign not provided 2024-03-25 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV001125426 SCV001284494 uncertain significance Autosomal recessive nonsyndromic hearing loss 77 2018-01-12 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
GeneDx RCV000901310 SCV001820134 uncertain significance not provided 2023-07-01 criteria provided, single submitter clinical testing Observed with a second LOXHD1 variant in a patient with deafness, but it is not known whether the variants occurred on the same (in cis) or on different (in trans) chromosomes (Li et al., 2021); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 33724713, 25668207)
PreventionGenetics, part of Exact Sciences RCV004751303 SCV005353861 likely benign LOXHD1-related disorder 2024-07-13 no assertion criteria provided clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.